Abdul Manaf Mohd Rizal, Surendra Naren Kumar, Abdul Gafor Abdul Halim, Seong Hooi Lai, Bavanandan Sunita
Department of Community Health, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
Nephrology Unit, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
Int J Nephrol. 2017;2017:5819629. doi: 10.1155/2017/5819629. Epub 2017 Oct 31.
End-stage renal disease (ESRD) is managed by either lifesaving hemodialysis (HD) and peritoneal dialysis (PD) or a kidney transplant. In Malaysia, the prevalence of dialysis-treated ESRD patients has shown an exponential growth from 504 per million population (pmp) in 2005 to 1155 pmp in 2014. There were 1046 pmp patients on HD and 109 pmp patients on PD in 2014. Kidney transplants are limited due to lack of donors. Malaysia adopts public-private financing model for dialysis. Majority of HD patients were treated in the private sector but almost all PD patients were treated in government facilities. Inequality in access to dialysis is visible within geographical regions where majority of HD centres are scattered around developed areas. The expenditure on dialysis has been escalating in recent years but economic evaluations of dialysis modalities are scarce. Evidence shows that health policies and reimbursement strategies influence dialysis provision. Increased uptake of PD can produce significant economic benefits and improve patients' access to dialysis. As a result, some countries implemented a PD-First or Favored Policy to expand PD use. Thus, a current comparative costs analysis of dialysis is strongly recommended to assist decision-makers to establish a more equitable and economically sustainable dialysis provision in the future.
终末期肾病(ESRD)通过挽救生命的血液透析(HD)、腹膜透析(PD)或肾移植进行治疗。在马来西亚,接受透析治疗的ESRD患者患病率呈指数增长,从2005年的每百万人口504例增长至2014年的每百万人口1155例。2014年,有1046例每百万人口的患者接受血液透析,109例每百万人口的患者接受腹膜透析。由于缺乏捐赠者,肾移植受限。马来西亚采用公私合营的透析融资模式。大多数血液透析患者在私立部门接受治疗,但几乎所有腹膜透析患者都在政府机构接受治疗。在地理区域内,透析服务的可及性存在不平等,大多数血液透析中心分布在发达地区。近年来,透析费用不断攀升,但对透析方式的经济评估却很少。有证据表明,卫生政策和报销策略会影响透析服务的提供。增加腹膜透析的使用可以产生显著的经济效益,并改善患者获得透析的机会。因此,一些国家实施了优先使用腹膜透析或支持腹膜透析的政策,以扩大腹膜透析的使用。因此,强烈建议进行当前透析的比较成本分析,以协助决策者在未来建立更公平、经济上可持续的透析服务。